Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07158489 |
| Title | Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC (ORIGIN2) |
| Acronym | ORIGIN2 |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Swiss Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Kantonsspital Baden | Baden | 5404 | Switzerland | Details | ||
| Universitätsspital Basel | Basel | 4031 | Switzerland | Details | ||
| IOSI Ospedale Regionale di Bellinzona e Valli | Bellinzona | 6500 | Switzerland | Details | ||
| Kantonsspital Graubuenden | Chur | CH-7000 | Switzerland | Details | ||
| Hôpital Fribourgeois - Hôpital Cantonal | Fribourg | Switzerland | Details | |||
| Hôpitaux Universitaires de Genève | Geneva | 1211 | Switzerland | Details | ||
| Kantonsspital Winterthur | Winterthur | 8401 | Switzerland | Details |